↓ Skip to main content

Validation of [18F]FLT as a perfusion-independent imaging biomarker of tumour response in EGFR-mutated NSCLC patients undergoing treatment with an EGFR tyrosine kinase inhibitor

Overview of attention for article published in EJNMMI Research, March 2018
Altmetric Badge

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
21 Mendeley